In conclusion, these data suggest that the stimulation of A2AR could represent a promising therapy for NPC disease because it can simultaneously impinge on many pathological events such as cholesterol accumulation, mitochondrial dysfunction, autophagy, and OLs differentiation. The gene discussed is ADORA2A; the disease is nasopharyngeal carcinoma.